Details of the Drug

General Information of Drug (ID: DMWE205)

Drug Name

DCR-MYC

Indication

Disease Entry	ICD 11	Status	REF
Hepatocellular carcinoma	2C12.02	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

siRNA drug

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
MYCBP messenger RNA (MYCBP mRNA)	TTVW4XU	MYCBP_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT02314052) Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma. U.S. National Institutes of Health.
2	National Cancer Institute Drug Dictionary (drug id 759983).